|
Complete objective response of oesophageal squamocellular carcinoma to biological treatment
|
12 June 2026 |
|
Low-grade non-Hodgkin lymphoma at advanced stage: a case successfully treated with cyclophosphamide plus somatostatin, bromocriptine, retinoids, and melatonin
|
11 June 2026 |
|
Relapse of high-grade non-Hodgkin's lymphoma after autologous stem cell transplantation: a case successfully treated with cyclophosphamide plus somatostatin, bromocriptine, melatonin, retinoids, and ACTH
|
10 June 2026 |
|
Cyclophosphamide plus somatostatin, bromocriptin, retinoids, melatonin and ACTH in the treatment of low-grade non-Hodgkin's lymphomas at advanced stage: results of a phase II trial
|
08 June 2026 |
|
Complete objective response of neuroblastoma to biological treatment
|
06 June 2026 |
|
Somatostatin, retinoids, melatonin, vitamin D, bromocriptine, and cyclophosphamide in chemotherapy-pretreated patients with advanced lung adenocarcinoma and low performance status
|
04 June 2026 |
|
Somatostatin, retinoids, melatonin, vitamin D, bromocriptine, and cyclophosphamide in advanced non-small-cell lung cancer patients with low performance status
|
03 June 2026 |
|
Chronic lymphocytic leukemia: long-lasting remission with combination of cyclophosphamide, somatostatin, bromocriptine, retinoids, melatonin, and ACTH
|
02 June 2026 |
|
Complete objective response to biological therapy of plurifocal breast carcinoma
|
29 May 2026 |
|
Melatonin: An Endogenous Antiestrogen with Oncostatic Properties
|
02 January 2026 |
News-Papers
Testimonial
Video Gallery 
